"Hospital General con amplía cartera de servicios y especialidades. Cuenta con 574 camas de hospitalización, Servicio de Urgencias, bloque quirúrgico, Hospital de día y Unidad de Consultas Externas"

During the past decade, Hospital General de Castellón conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 2 clinical trials were completed, i.e. on average, 13.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 2 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital General de Castellón" #1 sponsor was "PETHEMA Foundation" with 16 trials, followed by "Grupo Español de Rehabilitación Multimodal" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana" with 2 trials sponsored and "University of Valencia" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital General de Castellón" #1 collaborator was "Celgene" with 3 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia" with 1 trials as a collaborator, "GTEI" with 1 trials as a collaborator and "General University Hospital of Valencia" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Hospital General de Castellón" are "Multiple Myeloma" (5 trials), "Acute Lymphoblastic Leukemia" (3 trials), "HIV Infections" (3 trials), "Perioperative Care" (3 trials) and "Postoperative Complications" (3 trials). Many other conditions were trialed in "Hospital General de Castellón" in a lesser frequency.

Most popular intervention types in "Hospital General de Castellón" are "Drug" (26 trials), "Procedure" (4 trials), "Device" (3 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Prednisone" (5 trials), "Dexamethasone" (4 trials), "Daunorubicin" (3 trials), "Mercaptopurine" (3 trials) and "Mitoxantrone" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital General de Castellón" are 33 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital General de Castellón". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Hospital General de Castellón, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital General de Castellón, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 2 trials that are defined as “Not Applicable".